Lowering the cost of hepatitis C drugs is possible and key to achieving global access to treatment, according to new research by the University of Liverpool and Imperial College London.
Feb 23, 2015
5 / 5 (3) | 0
When patients with glaucoma switched from a brand name drug to its generic counterpart, they were more likely to take their medication as directed compared to those who remained on the brand name drug, according ...
Feb 11, 2015
5 / 5 (1) | 0